Spots Global Cancer Trial Database for Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Official Title: Basis Plan For Postmarketing Survelillances, Etc. Of New Ethical Drugs For Torisel
Study ID: NCT01210482
Conditions
Interventions
Study Description
Brief Summary: The objective of this investigation is to determine the following items in all patients receiving Torisel for a certain period after marketing: 1. Confirmation of efficacy and safety for medical practice use. 2. Investigation of factors that may influence the incidence of adverse events (Particularly priority investigation items). 3. Investigation of the incidence status and the risk factors for interstitial lung diseases.
Detailed Description: Implemented as a Drug Use Investigation by Central Registration System
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kyusyu University Hospital, Fukuoka-shi, Fukuoka PREF, Japan
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
